GEODE CAPITAL MANAGEMENT, LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 73 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,771,000
+0.1%
360,738
+7.6%
0.00%
Q2 2021$1,769,000
+27.9%
335,106
+16.2%
0.00%
Q1 2021$1,383,000
+102.2%
288,275
+82.3%
0.00%
Q4 2020$684,000
+5.4%
158,113
+0.3%
0.00%
Q3 2020$649,000
+61.0%
157,6450.0%0.00%
Q2 2020$403,000
-52.9%
157,645
-46.7%
0.00%
Q1 2020$855,000
-62.4%
295,932
-50.8%
0.00%
Q4 2019$2,276,000
+67.0%
600,914
+125.4%
0.00%
Q3 2019$1,363,000
-17.0%
266,555
+0.6%
0.00%
Q2 2019$1,642,000
-4.5%
264,869
+9.5%
0.00%
Q1 2019$1,719,000
-56.8%
241,793
-48.1%
0.00%
-100.0%
Q4 2018$3,976,000
-8.9%
465,800
+113.7%
0.00%0.0%
Q3 2018$4,364,000
-15.0%
217,998
+9.6%
0.00%
-50.0%
Q2 2018$5,137,000
+25.2%
198,894
+15.8%
0.00%
+100.0%
Q1 2018$4,103,000
-16.3%
171,703
+18.7%
0.00%
-50.0%
Q4 2017$4,900,000
+82.2%
144,614
+13.8%
0.00%
+100.0%
Q3 2017$2,689,000
+21.7%
127,044
+0.5%
0.00%0.0%
Q2 2017$2,209,000
+0.4%
126,354
+0.4%
0.00%0.0%
Q1 2017$2,201,000
+8.7%
125,793
+4.9%
0.00%0.0%
Q4 2016$2,025,000
+7.7%
119,873
+4.6%
0.00%0.0%
Q3 2016$1,881,000
+10.8%
114,631
+2.2%
0.00%0.0%
Q2 2016$1,698,000
+31.3%
112,201
+25.4%
0.00%0.0%
Q1 2016$1,293,000
-39.0%
89,468
+19.6%
0.00%0.0%
Q4 2015$2,119,000
+146.1%
74,835
+45.4%
0.00%0.0%
Q3 2015$861,000
-33.1%
51,486
+4.8%
0.00%0.0%
Q2 2015$1,287,000
+73.9%
49,123
+16.1%
0.00%
Q1 2015$740,000
+8.0%
42,319
+7.2%
0.00%
Q4 2014$685,000
+109.5%
39,474
+124.3%
0.00%
Q3 2014$327,000
+2.5%
17,597
+0.8%
0.00%
Q2 2014$319,00017,4510.00%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders